Trends in Women With an HIV Diagnosis at Delivery Hospitalization in the United States, 2006-2014.


Journal

Public health reports (Washington, D.C. : 1974)
ISSN: 1468-2877
Titre abrégé: Public Health Rep
Pays: United States
ID NLM: 9716844

Informations de publication

Date de publication:
Historique:
pubmed: 11 7 2020
medline: 22 8 2020
entrez: 11 7 2020
Statut: ppublish

Résumé

The risk of mother-to-child HIV transmission can be reduced to ≤0.5% if the mother's HIV status is known before delivery. This study describes 2006-2014 trends in diagnosed HIV infection documented on delivery discharge records and associated sociodemographic characteristics among women who gave birth in US hospitals. We analyzed data from the 2006-2014 National Inpatient Sample and identified delivery discharges and women with diagnosed HIV infection by using During 2006-2014, an HIV diagnosis was documented on approximately 3900-4400 delivery discharge records annually. The probability of having an HIV diagnosis on delivery discharge records decreased 3% per year (adjusted relative risk [aRR] = 0.97; 95% CI, 0.94-0.99), with significant declines identified among white women aged 25-34 (aRR = 0.93; 95% CI, 0.88-0.97) or those using Medicaid (aRR = 0.93; 95% CI, 0.90-0.97); among black women aged 25-34 (aRR = 0.95; 95% CI, 0.92-0.99); and among privately insured women who were black (aRR = 0.96; 95% CI, 0.92-0.99), Hispanic (aRR = 0.92; 95% CI, 0.86-0.98), or aged 25-34 (aRR = 0.96; 95% CI, 0.92-0.99). The probability of having an HIV diagnosis on delivery discharge records was greater for women who were black (aRR = 8.45; 95% CI, 7.56-9.44) or Hispanic (aRR = 1.56; 95% CI, 1.33-1.83) than white; for women aged 25-34 (aRR = 2.33; 95% CI, 2.12-2.55) or aged ≥35 (aRR = 3.04; 95% CI, 2.79-3.31) than for women aged 13-24; and for Medicaid recipients (aRR = 2.70; 95% CI, 2.45-2.98) or the uninsured (aRR = 1.87; 95% CI, 1.60-2.19) than for privately insured patients. During 2006-2014, the probability of having an HIV diagnosis declined among select sociodemographic groups of women delivering neonates. High-impact prevention efforts tailored to women remaining at higher risk for HIV infection can reduce the risk of mother-to-child HIV transmission.

Identifiants

pubmed: 32649273
doi: 10.1177/0033354920935074
pmc: PMC7383760
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

524-533

Références

Am J Obstet Gynecol. 2016 Oct;215(4):499.e1-8
pubmed: 27263995
MMWR Recomm Rep. 2001 May 11;50(RR-6):17-28
pubmed: 15580801
MMWR Recomm Rep. 1994 Aug 5;43(RR-11):1-20
pubmed: 7913986
J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):218-22
pubmed: 21372725
Health Serv Res. 2007 Apr;42(2):908-27
pubmed: 17362224
Med Care. 2017 Nov;55(11):918-923
pubmed: 28930890
Arch Gynecol Obstet. 2017 Mar;295(3):599-606
pubmed: 28097445
Natl Vital Stat Rep. 2015 Dec;64(12):1-64
pubmed: 26727629
Natl Vital Stat Rep. 2009 Apr 17;57(14):1-134
pubmed: 19788058
JAMA Pediatr. 2017 May 1;171(5):435-442
pubmed: 28319246
Pediatrics. 2012 Oct;130(4):738-44
pubmed: 22945404
Pediatrics. 2012 Jan;129(1):e74-81
pubmed: 22144694
Natl Vital Stat Rep. 2015 Jul 23;64(8):1-24
pubmed: 26222771
Int J Gynaecol Obstet. 2001 Jun;73(3):279-81
pubmed: 11424912
Fed Regist. 2007 Aug 22;72(162):47129-8175
pubmed: 17847578
South Med J. 2017 Feb;110(2):116-128
pubmed: 28158882
Clin Infect Dis. 2017 Feb 15;64(4):527-528
pubmed: 28174911
MMWR Morb Mortal Wkly Rep. 1985 Dec 6;34(48):721-6, 731-2
pubmed: 2999576
Am J Obstet Gynecol. 2017 Jan;216(1):71.e1-71.e16
pubmed: 27640942
MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):985-8
pubmed: 21796096
Natl Vital Stat Rep. 2012 Jun 20;60(7):1-21
pubmed: 22970648
Am J Prev Med. 2005 Feb;28(2):175-81
pubmed: 15710273

Auteurs

Maria Vyshnya Aslam (MV)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Kwame Owusu-Edusei (K)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Steven R Nesheim (SR)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Kristen Mahle Gray (KM)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Margaret A Lampe (MA)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Patricia Marie Dietz (PM)

1242 National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH